A C-Linked Disaccharide Analogue of Thomsen-Friedenreich Epitope Induces a Strong Immune Response in Mice
A C-Linked Disaccharide Analogue of Thomsen-Friedenreich Epitope Induces a Strong Immune Response in Mice
复制标题
DOI:
10.1002/chem.201200364
复制
发表时间:
2012-07-09
影响因子:
4.3
通讯作者:
Vogel, Pierre
中科院分区:
文献类型:
--
作者:
Awad, Loay;Madani, Rime;Vogel, Pierre
Cancer cells can express aberrant cell-surface-glycosylation patterns that makes them to be recognizable by the immune system.[1] This phenotype gives an opportunity to develop carbohydrate-based vaccines for cancer immunotherapy.[2] Thomsen–Friedenreich (TF) antigen is a disaccharide (β-d-Galp-1-3-α-d-GalNAcp) oncofetal blood group-related antigen normally O-linked to serines or threonines of mucines (MUC) expressed on cells at the secretory borders of epithelial tissues. The disaccharide is linked to malignancy and plays an important role in docking breast-and prostate-cancer cells onto endothelium.[3] Patients immunized with synthetic TF-Keyhole limpet hemocyanin KLH conjugate vaccines, plus various adjuvants can generate high-titer IgM and IgG antibodies.[4] Antigen 1 constructed from a disaccharide tripeptide cluster conjugated to KLH (+ adjuvant QS-21) has been shown by Danishefsky and co-workers to be a relevant antigen target in a multivalent phase II-vaccine trial in patients with high-risk minimal prostate cancer.[5] Because the disaccharide moiety of TF-epitope β-d-Galp-1-3-α-d-GalNAcp-Ol-serine is hydrolyzed by β-galactosidases in the body,[6] there is a need for more stable antigens than 1. Under similar conditions as reported for 1, we have now found that the C-disaccharide analogue 2 with QS21 as adjuvant [7] induces a strong immune response in mice after two boosts. This suggests that C-disaccharides can be used to construct therapeutic vaccines against cancer and other diseases. Much weaker immune response was observed when using antigen 3 constructed from α-d-Galp-1ACHTUNGTRENNUNG (CH2)-3-α-d-GalNAcp-O-serine (a α-C-galactoside rather than β-C-galactoside as in 2; Figure 1).Various strategies towards the incorporation of non-natural hydrolysis-resistant carbohydrate analogues into vaccine constructs have been explored, including the use of C-glycosides [8] and S-glycosides [8b, 9] analogues of O-glycosides, as well as O-deoxyfluoroglycosides.[10] It has been proposed also to use β3-homothreonine conjugates instead of threonine or serine to construct mucin-like glycopeptides antigen analogues.[11] In this report, we have explored whether the replacement of the O-linked disaccharide moiety in a C-linked disaccharide analogue would still induce an immune response, and whether the latter would depend on the β-or α-configuration of the d-galalactopyranoside moiety of the artificial antigen. The exchange of one acetal oxygen atom for a CH2 group (change from acetal to ether function) modifies the polarity and water solubility of the disaccharide, as well as the population of its conformers about the two interglycosidic bonds. Several studies have suggested that the energy maps of C-linked disaccharides are similar to maps of the corresponding O-disaccharides, but there are differences in the locations and the relative free energies of the minima.[12] For example, with β-d-Galp-(1ACHTUNGTRENNUNG (CH2)-4)-β-d-GlcNAcp-OMe, the C-disaccharide populates three distinctive conformational families in water solution, the major one being the anti-Y-conformation, which is only marginally populated for the O-linked disaccharide.[13] The construction of antigens 2 and 3 are outlined in Schemes 1 and 2, respectively, and are described in details in the Supporting Information. The synthesis of the C-disaccharide mimetic of the TF-disaccharide started with aldehyde 4.[14] Itoh–Nozaki condensation [15] of 4 with isolevoglu-